Skip to content

Effect evaluation of different moxibustion amounts for treating chronic obstructive pulmonary disease based on real-time monitoring system of body surface temperature

Development and clinical application of moxibustion for real-time monitoring system of body surface temperature in treating chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061233
Enrollment
Unknown
Registered
2022-06-16
Start date
2022-06-04
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Group A:3 cm thick cashmere with 60 min treatment time
Group B:3 cm thick cashmere with 90 min treatment time
Group C:2 cm thick cashmere with 60 min treatment time
Group D:2 cm thick cashmere with 90 min treatment time

Sponsors

The First Affiliated Hospital of Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with stable COPD who meet the above diagnostic criteria; 2. Meet the TCM syndrome differentiation criteria of lung-qi deficiency, lung-qi deficiency, and lung-kidney deficiency; 3. Age 18-80 years old; 4. Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating patients; 2. Patients with cognitive impairment, confusion, dementia, and various mental illnesses; 3. Patients with unstable angina and acute myocardial infarction; 4. Previous history of syncope after exercise, osteoarthritis affecting exercise; 5. Patients with pneumothorax, pleural effusion, pulmonary embolism, and tumor; 6. Those who are known to be allergic to the ingredients of moxibustion powder.

Design outcomes

Primary

MeasureTime frame
6-minute walk distance;

Secondary

MeasureTime frame
Modified version of the British Medical Research Council dyspnea scale;Lung function;Clinical signs and symptoms questionnaire;Body surface temperature;numerical rating scale;COPD Assessment Test;Modified COPD patient reported outcome scale;Modified Efficacy satisfaction questionnaire for COPD patients;Evaluation of skin sensitization;Number of exacerbations;

Countries

China

Contacts

Public ContactYang Xie

The First Affiliated Hospital of Henan University of Chinese Medicine

xieyanghn@163.com+86 13526621325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026